Children's Hospital is part of the UPMC family.
Be safe anytime, anywhere.
To find a pediatrician or pediatric specialist, please call 412-692-7337 or search our directory.
A resource for our network of referring physicians.
For more information about research, please call our main office at 412-692-6438.
Ranked #8 Nationally by U.S. News & World Report.
The Konnikova Lab has identified that signaling via the innate immune receptor, Toll-like receptor 4 (TLR4) plays a key role in the development of NEC. We now seek to identify novel biomarkers for NEC in a longitudinal cohort study of infants with NEC, who are born at a major neonatal center, by assessing the TLR4 signaling capacity of these neonates using combined in vitro and in silico approaches. In so doing, we hope to advance the field by identifying newborns that are at risk for NEC development, thus creating a window for early prophylactic and interventional therapies.
Every year more than 500,000 infants are born prematurely (prior to 37-weeks' gestation) in the United States, which is equivalent to one in every eight babies being born prematurely. Preterm birth (PTB) has been correlated with greater risk for many conditions that require an infant to spend time in Neonatal Intensive Care Units (NICU). However, the underlying causes of PTB have not been completely elucidated.
A link between preterm birth and placental inflammation has been reported in both infection-driven and non-infection-driven cases of PTB, but the specific cell types and signaling pathways involved remain unclear. Infants born preterm are at greater risk for multiple complications including sepsis, particularly in the first few days of life which can lead to severe neurodevelopmental complications or death in afflicted infants. Evidence suggests immune dysregulation may contribute to both the onset of PTB and increased risk of sepsis.
The role of the placenta in immune regulation and its impact on the outcomes of the neonate has not been fully explored. This has in part been difficult due to the large repertoire of cells and signaling molecules related to immune homeostasis that need to be investigated. To address this issue, our study utilizes the placenta and cord blood samples collected through the Magee Obstetric Maternal & Infant (MOMI) Biobank and processes them using mass cytometry (CyTOF) to simultaneously analyze 40 antibody cell surface and signaling markers at single cell resolutions to comprehensively evaluate cell populations. CyTOF also has the potential to aid in uncovering inflammatory signaling cascades by segregating cell types based on intracellular phosphorylated proteins and stimulated cytokine concentrations. In the current study we aim to systematically characterize the immune profile of the placenta and cord blood. We will then take the immune profile and correlate it to the clinical presentation of the mother and the clinical outcomes of the neonate.
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Visit Children's Hospital of Pittsburgh Foundation's website to make a donation online.